Cargando…

A semi-quantitative, rapid, point of care SARS-CoV-2 serologic assay predicts neutralizing antibody levels

The ongoing COVID-19 pandemic has caused millions of deaths and the continued emergence of new variants suggests continued circulation in the human population. In the current time of vaccine availability and new therapeutic development, including antibody-based therapies, many questions about long-t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Markmann, Alena J., Bhowmik, D. Ryan, Jiang, Baowei, Van Hoy, Michael, Wang, Frank, Hou, Yixuan J., Baric, Ralph S., de Silva, Aravinda M., Bartelt, Luther A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10312490/ https://www.ncbi.nlm.nih.gov/pubmed/37398270 http://dx.doi.org/10.1101/2023.05.30.542314

Ejemplares similares

Outcomes of Convalescent Plasma with Defined High versus Lower Neutralizing Antibody Titers against SARS-CoV-2 among Hospitalized Patients: CoronaVirus Inactivating Plasma (CoVIP) Study
por: Bartelt, Luther A., et al.
Publicado: (2022)

Sex disparities and neutralizing antibody durability to SARS-CoV-2 infection in convalescent individuals
por: Markmann, Alena J., et al.
Publicado: (2021)

Sex Disparities and Neutralizing-Antibody Durability to SARS-CoV-2 Infection in Convalescent Individuals
por: Markmann, Alena J., et al.
Publicado: (2021)

Erratum for Markmann et al., “Sex Disparities and Neutralizing-Antibody Durability to SARS-CoV-2 Infection in Convalescent Individuals”
por: Markmann, Alena J., et al.
Publicado: (2021)

Towards Quantitative and Standardized Serological and Neutralization Assays for COVID-19
por: Tian, Linhua, et al.
Publicado: (2021)

Human dengue virus serotype 2 neutralizing antibodies target two distinct quaternary epitopes
por: Gallichotte, Emily N., et al.
Publicado: (2018)

The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients
por: Premkumar, Lakshmanane, et al.
Publicado: (2020)

Combining antibody markers for serosurveillance of SARS-CoV-2 to estimate seroprevalence and time-since-infection – CORRIGENDUM
por: Bhuiyan, Md S., et al.
Publicado: (2021)

Role of Zika Virus Envelope Protein Domain III as a Target of Human Neutralizing Antibodies
por: Gallichotte, Emily N., et al.
Publicado: (2019)

Correlation between In Vitro Neutralization Assay and Serological Tests for Protective Antibodies Detection
por: Bonifacio, Maria Addolorata, et al.
Publicado: (2022)

Optimization of a Quantitative Micro-neutralization Assay
por: Lin, Yipu, et al.
Publicado: (2016)

Evaluation of Serological SARS-CoV-2 Lateral Flow Assays for Rapid Point-of-Care Testing
por: Conklin, Steven E., et al.
Publicado: (2021)

An Assessment of Serological Assays for SARS-CoV-2 as Surrogates for Authentic Virus Neutralization
por: Wohlgemuth, Nicholas, et al.
Publicado: (2021)

A Rapid, Semi-Quantitative Assay to Screen for Modulators of Alpha-Synuclein Oligomerization Ex vivo
por: Delenclos, Marion, et al.
Publicado: (2016)

A rapid and quantitative assay for measuring neutralizing antibodies of Coxsackievirus B3
por: Chen, Pan, et al.
Publicado: (2016)

SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo
por: Hou, Yixuan J., et al.
Publicado: (2020)

Rapid point-of-care testing for COVID-19: quality of supportive information for lateral flow serology assays
por: Kierkegaard, Patrick, et al.
Publicado: (2021)

Natural Strain Variation and Antibody Neutralization of Dengue Serotype 3 Viruses
por: Wahala, Wahala M. P. B., et al.
Publicado: (2010)

Genetic Variation between Dengue Virus Type 4 Strains Impacts Human Antibody Binding and Neutralization
por: Gallichotte, Emily N., et al.
Publicado: (2018)

Evaluation of a Quantitative Serological Assay for Diagnosing Chronic Pulmonary Aspergillosis
por: Fujiuchi, Satoru, et al.
Publicado: (2016)

A Semi-Quantitative Assay to Measure Glycosaminoglycan Degradation by the Urinary Microbiota
por: Nguyen, Vivian H., et al.
Publicado: (2022)

Defining levels of dengue virus serotype-specific neutralizing antibodies induced by a live attenuated tetravalent dengue vaccine (TAK-003)
por: White, Laura J., et al.
Publicado: (2021)

SARS-CoV-2-Neutralizing Antibody Response and Correlation of Two Serological Assays with Microneutralization
por: Souiri, Amal, et al.
Publicado: (2023)

Scalable, semi-automated fluorescence reduction neutralization assay for qualitative assessment of Ebola virus-neutralizing antibodies in human clinical samples
por: Postnikova, Elena N., et al.
Publicado: (2019)

Antigenic Variation of the Dengue Virus 2 Genotypes Impacts the Neutralization Activity of Human Antibodies in Vaccinees
por: Martinez, David R., et al.
Publicado: (2020)

Development and Characterization of a Reverse Genetic System for Studying Dengue Virus Serotype 3 Strain Variation and Neutralization
por: Messer, William B., et al.
Publicado: (2012)

Two-dimensional multiplexed assay for rapid and deep SARS-CoV-2 serology profiling and for machine learning prediction of neutralization capacity
por: Koide, Akiko, et al.
Publicado: (2021)

Lack of Durable Cross-Neutralizing Antibodies Against Zika Virus from Dengue Virus Infection
por: Collins, Matthew H., et al.
Publicado: (2017)

Ultra-Sensitive and Semi-Quantitative Vertical Flow Assay for the Rapid Detection of Interleukin-6 in Inflammatory Diseases
por: Lei, Rongwei, et al.
Publicado: (2022)

Serological reactivity of inactivated SARS-CoV-2 vaccine based on an S-RBD neutralizing antibody assay
por: Zhang, Hui, et al.
Publicado: (2022)

A serological aptamer-assisted proximity ligation assay for COVID-19 diagnosis and seeking neutralizing aptamers
por: Liu, Ran, et al.
Publicado: (2020)

Evaluation of a COVID-19 convalescent plasma program at a U.S. academic medical center
por: Root, Heather B., et al.
Publicado: (2022)

A rapid simple point-of-care assay for the detection of SARS-CoV-2 neutralizing antibodies
por: Kongsuphol, Patthara, et al.
Publicado: (2021)

A Novel Antigenic Site Spanning Domains I and III of the Zika Virus Envelope Glycoprotein Is the Target of Strongly Neutralizing Human Monoclonal Antibodies
por: Graham, Stephen D., et al.
Publicado: (2021)

Tracking the polyclonal neutralizing antibody response to a dengue virus serotype 1 type-specific epitope across two populations in Asia and the Americas
por: Andrade, Daniela V., et al.
Publicado: (2019)

Semi-Functional Quantitative Flow Cytometry Assay for Lymphocytic Choriomeningitis Virus Titration
por: Ban, Young Ho, et al.
Publicado: (2017)

Semi-Quantitative Assay to Measure Urease Activity by Urinary Catheter-Associated Uropathogens
por: Duran Ramirez, Jesus M., et al.
Publicado: (2022)

A rapid and flexible microneutralization assay for serological assessment of influenza viruses
por: Rumfelt, Kalee E., et al.
Publicado: (2023)

SARS-CoV-2 Serologic Assays in Control and Unknown Populations Demonstrate the Necessity of Virus Neutralization Testing
por: Rathe, Jennifer A, et al.
Publicado: (2020)

Evaluation of Cell-Based and Surrogate SARS-CoV-2 Neutralization Assays
por: Sholukh, Anton M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_afd7l6034c1iiqogb85j5ghqn4